Steroid-Free Versus Steroid-Containing Immunosuppression for Liver Transplant Recipients.
作者信息
Fairfield Cameron J, Harrison Ewen M, Wigmore Stephen J, VanWagner Lisa B
机构信息
Centre for Medical Informatics The Usher Institute University of Edinburgh Edinburgh United Kingdom.
Department of Clinical Surgery University of Edinburgh Edinburgh United Kingdom.
出版信息
Clin Liver Dis (Hoboken). 2020 Dec 10;16(5):191-195. doi: 10.1002/cld.992. eCollection 2020 Nov.
Abstract
摘要
相似文献
1
Steroid-Free Versus Steroid-Containing Immunosuppression for Liver Transplant Recipients.肝移植受者无类固醇与含类固醇免疫抑制治疗的对比
Clin Liver Dis (Hoboken). 2020 Dec 10;16(5):191-195. doi: 10.1002/cld.992. eCollection 2020 Nov.
2
Steroid-free maintenance immunosuppression with rapamune and low-dose neoral in pancreas transplant recipients.胰腺移植受者使用雷帕霉素和低剂量新山地明进行无类固醇维持免疫抑制治疗。
Transplantation. 2007 Nov 15;84(9):1131-7. doi: 10.1097/01.tp.0000287117.98785.54.
3
Excellent clinical outcomes in primary kidney transplant recipients treated with steroid-free maintenance immunosuppression.接受无类固醇维持免疫抑制治疗的原发性肾移植受者的临床效果良好。
Clin Transplant. 2006 Sep-Oct;20(5):537-46. doi: 10.1111/j.1399-0012.2006.00521.x.
4
Comprehensive comparison of three different immunosuppressive regimens for liver transplant patients with hepatocellular carcinoma: steroid-free immunosuppression, induction immunosuppression and standard immunosuppression.三种不同免疫抑制方案用于肝细胞癌肝移植患者的综合比较：无类固醇免疫抑制、诱导免疫抑制和标准免疫抑制。
PLoS One. 2015 Mar 27;10(3):e0120939. doi: 10.1371/journal.pone.0120939. eCollection 2015.
5
Early steroid withdrawal therapy in renal transplant recipients: a steroid-free sirolimus and CellCept-based calcineurin inhibitor-minimization protocol.肾移植受者的早期类固醇撤药疗法：一种基于无类固醇西罗莫司和骁悉的钙调神经磷酸酶抑制剂最小化方案。
Clin Transplant. 2007 Jan-Feb;21(1):101-9. doi: 10.1111/j.1399-0012.2006.00613.x.
6
Identifying risk profiles in liver transplant candidates and implications for induction immunosuppression.识别肝移植候选者的风险特征及其对诱导免疫抑制的影响。
Transplant Rev (Orlando). 2018 Jul;32(3):142-150. doi: 10.1016/j.trre.2018.04.001. Epub 2018 Apr 13.
7
Comparison of four different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: five-year outcomes.在接受监测活检的肾移植受者中，四种不同的无长期类固醇治疗免疫抑制方案的比较：五年结果
Transpl Immunol. 2008 Nov;20(1-2):32-42. doi: 10.1016/j.trim.2008.08.005. Epub 2008 Sep 4.
8
Reduction in corticosteroids is associated with better health-related quality of life after liver transplantation.肝移植后糖皮质激素的减少与更好的健康相关生活质量相关。
J Am Coll Surg. 2012 Feb;214(2):164-73. doi: 10.1016/j.jamcollsurg.2011.10.006. Epub 2011 Dec 3.
9
Corticosteroids in kidney transplant recipients. Safety issues and timing of discontinuation.肾移植受者中的皮质类固醇。安全问题及停用时机
Drug Saf. 1995 Sep;13(3):145-56. doi: 10.2165/00002018-199513030-00002.
10
Improved cardiovascular risk factors in pediatric renal transplant recipients on steroid avoidance immunosuppression: A study of the Midwest Pediatric Nephrology Consortium.接受避免使用类固醇免疫抑制治疗的小儿肾移植受者心血管危险因素的改善：中西部小儿肾脏病学联合会的一项研究
Pediatr Transplant. 2016 Feb;20(1):59-67. doi: 10.1111/petr.12633. Epub 2015 Nov 20.
引用本文的文献
1
Safety and efficacy of early corticosteroid withdrawal in liver transplant recipients: A randomized controlled trial.肝移植受者早期停用皮质类固醇的安全性和有效性：一项随机对照试验。
Ann Hepatobiliary Pancreat Surg. 2024 May 31;28(2):238-247. doi: 10.14701/ahbps.23-129. Epub 2024 Mar 15.
2
Introducing "From Evidence to Practice": Summarizing Systematic Reviews in Hepatology for the Practicing Clinician.推出《从证据到实践》：为临床医生总结肝病学系统评价
Clin Liver Dis (Hoboken). 2020 Dec 10;16(5):196-197. doi: 10.1002/cld.993. eCollection 2020 Nov.
本文引用的文献
1
The harms of early cessation of trials on systematic reviews.系统评价中提前终止试验的危害。
Lancet Gastroenterol Hepatol. 2019 Sep;4(9):667. doi: 10.1016/S2468-1253(19)30192-X.
2
Glucocorticosteroid-free versus glucocorticosteroid-containing immunosuppression for liver transplanted patients.肝移植患者使用不含糖皮质激素与含糖皮质激素的免疫抑制治疗对比
Cochrane Database Syst Rev. 2018 Apr 9;4(4):CD007606. doi: 10.1002/14651858.CD007606.pub4.
3
Factors Associated With Major Adverse Cardiovascular Events After Liver Transplantation Among a National Sample.全国样本中肝移植术后主要不良心血管事件的相关因素
Am J Transplant. 2016 Sep;16(9):2684-94. doi: 10.1111/ajt.13779. Epub 2016 Mar 29.
4
High early cardiovascular mortality after liver transplantation.肝移植后早期心血管死亡率高。
Liver Transpl. 2014 Nov;20(11):1306-16. doi: 10.1002/lt.23950. Epub 2014 Oct 24.
5
Metabolic syndrome and liver transplantation: a review and guide to management.代谢综合征与肝移植：综述及处理指南
J Hepatol. 2010 Jul;53(1):199-206. doi: 10.1016/j.jhep.2010.01.040. Epub 2010 Mar 31.
6
GRADE: an emerging consensus on rating quality of evidence and strength of recommendations.GRADE：关于证据质量评级和推荐强度的新共识。
BMJ. 2008 Apr 26;336(7650):924-6. doi: 10.1136/bmj.39489.470347.AD.
Zotero 插件